Program
The following programs listed below are to take place physically on June 20-22 at PACIFICO YOKOHAMA North. On-demand videos are available for the participants at post-meeting website from July 11 to August 1.
Please note that Live-streaming during the meeting period is NOT available.
Invited Lecture 1
The Intersection of Kidney Disease and Aging
- Date
- 11:05am - 11:55am, Friday, June 20
- Venue
- Room 1(1F G3+G4)
- Chair
- Masaomi NangakuThe University of Tokyo
- Speaker
- Stuart J. ShanklandUniversity of Washington
Invited Lecture 2
Neural Control of Inflammation in AKI: from Mouse to Humans
- Date
- 11:05am - 11:55am, Saturday, June 21
- Venue
- Room 1(1F G3+G4)
- Chair
- Naoki KashiharaKawasaki Geriatric Medical Center
- Speaker
- Mark D. OkusaUniversity of Virginia
Invited Lecture 3
Improving diagnosis and treatment in Alport syndrome through international collaboration
- Date
- 11:05am - 11:55am, Sunday, June 22
- Venue
- Room 1(1F G3+G4)
- Chair
- Reiko InagiThe University of Tokyo
- Speaker
- Rachel LennonUniversity of Manchester
Oshima Award Lectures
- Date
- 1:30pm - 2:00pm, Friday, June 20
- Venue
- Room 1(1F G3+G4)
- Chair
- Hirokazu OkadaSaitama Medical University
- Speaker
- Hiroaki KikuchiInstitute of Science Tokyo
- Speaker
- Kotaro HaruharaThe Jikei University School of Medicine
1.Energy Metabolism Disorders in the Kidney and AMPK: A Novel
Approach to Kidney Failure Treatment
2.Podometrics as an analytic platform for a better
understanding of kidney disease
CSA (Clinical Scientist Award) Lectures
- Date
- 2:00pm - 2:30pm, Friday, June 20
- Venue
- Room 1(1F G3+G4)
- Chair
- Akira NishiyamaKagawa University
- Speaker
- Noriaki KuritaFukushima Medical University
- Speaker
- Yoko ShiraiTokyo Women's Medical University
1.Advancing clinical epidemiology in nephrology: Integrating
biomarkers, treatment strategies, and patient-centered care
2.Anti-nephrin autoantibodies in podocytopathies
YIA (Young Investigator Award) Lectures
- Date
- 1:40pm - 2:55pm, Sunday, June 22
- Venue
- Room 7(3F G318+G319)
- Chair
- Fumiaki AndoInstitute of Science Tokyo
- Chair
- Shoji KuwabaraThe University of Shiga Prefecture
President-Organized Program / JSN Next Frontiers 2028 committee Program
Approaches to International Collaborative Research and the Utilization of Databases
- Date
- 9:00am - 11:00am, Saturday, June 21
- Venue
- Room 1(1F G3+G4)
- Chair
- Eisei SoharaInstitute of Science Tokyo
- Chair
- Ayumu NakashimaUniversity of Yamanashi
- Speaker
- Marcello TonelliUniversity of Calgary
- Speaker
- Motoko YanagitaKyoto University
- Speaker
- Ken SuzukiThe University of Tokyo
- Speaker
- Megumi OhshimaKanazawa University
- Speaker
- Jun WadaOkayama University
1.Encourage international collaborations: schemes of the ISN
2.What we gain from international joint research
3.Genomic Data Science for Diabetes Promoted Through
International Collaboration
4.Benefits and challenges of using databases in international
collaborative research
5.Promotion of international collaborative research and a
message to young researchers
Congress President-Organized Special Program 2
How to perform evolutionary research
- Date
- 9:00am - 11:00am, Sunday, June 22
- Venue
- Room 1(1F G3+G4)
- Chair
- Tsuyoshi InoueNagasaki University
- Chair
- Imari MimuraThe University of Tokyo Hospital
- Speaker
- Atsushi Miyawaki RIKEN/Center for Advanced Photonics
- Speaker
- Takanori TakebeOsaka University / Institute of Science Tokyo / Yokohama City University / Cincinnati Children's Hospital Medical Center
- Speaker
- Tomoko TakanoMcGill University
- Speaker
- Sydney TangThe University of Hong Kong
- Speaker
- Reiko InagiThe University of Tokyo
1 Cruising inside cells
2.Invent and Wander
3.Bridging the gap to build the autoimmune architecture of
nephrotic syndrome
4.Preparing a journey in academic research
5.Publishing Innovative Research to the World: An Editor’s
Perspective
Symposium 2
Perivascular cells protect kidney homeostasis
- Date
- 9:00am - 11:30am, Friday, June 20
- Venue
- Room 2(3F G301+G302)
- Chair
- Kaori HayashiKeio University
- Chair
- Kensei TaguchiKurume University
- Speaker
- Shinji TanakaThe University of Tokyo Hospital
- Speaker
- Takuo HiroseTohoku Medical and Pharmaceutical University
- Speaker
- Takahisa YoshikawaKyoto University Hospital
- Speaker
- Shun MinatoguchiFujita Health University
- Speaker
- Miki NagaseKyorin University
- Speaker
- Georgina Gyarmati University of Southern California, Keck School of Medicine
1.Roles of perivascular cells in kidney disease
2.Pericyte and renal congestion
3.Fibroblasts in the perivascular inflammatory
microenvironment and tertiary lymphoid structure formation
4.A novel renal mesenchymal perivascular cell subset that
expresses Meflin and gives rise to fibroblasts distinct from classic myofibroblasts
5.Role of the mechanosensor Piezo2 in perivascular mesenchymal
cells
6.Neuronally differentiated endothelial cell subtype regulates
organ blood flow and immune balance
Symposium 9
Treatment paradigm for IgA nephropathy: Looking ahead to the next decade
- Date
- 9:00am - 11:00am, Saturday, June 21
- Venue
- Room 2(3F G301+G302)
- Chair
- Wako YumuraTohoku Medical and Pharmaceutical University Hospital
- Chair
- Yoshihito NiheiJuntendo University
- Speaker
- Kentaro KoikeThe Jikei University School of Medicine
- Speaker
- Shuichi ItoYokohama City University
- Speaker
- Seiji UedaShimane University
- Speaker
- Kazuo TakahashiFujita Health University
- Speaker
- Jonathan Barratt University of Leicester
1.Tonsillectomy and Pulse Therapy in IgA Nephropathy: Past
Achievements and Future Perspectives
2.New developments in complement inhibition therapy for IgA
nephropathy
3.Endothelin receptor antagonists in treatment with IgA
nephropathy
4.Insights on the treatment of IgA nephropathy with a
targeted-release formulation of budesonide
5.Evolving treatment guidelines for IgAN-where are we going
next?
Symposium 14
Current situation and future direction of DKD management
- Date
- 2:00pm - 4:00pm, Saturday, June 21
- Venue
- Room 2(3F G301+G302)
- Chair
- Kei FukamiKurume University
- Chair
- Shinji KumeShiga University of Medical Science
- Speaker
- Keizo KanasakiShimane University
- Speaker
- Kengo FuruichiKanazawa Medical University
- Speaker
- Megumi OshimaKanazawa University
- Speaker
- Koki MiseOkayama University
- Speaker
- Christoph Wanner University of Würzburg
1.Current situation of DKD: Diversifying pathological
conditions
2.Current Understanding of Diabetic Kidney Disease: Expanding
Perspectives on Kidney Pathology
3.Current situation of DKD: Novel therapeutic strategy
4.Targeting mitochondrial electron transport chain remodeling
is a novel therapeutic strategy of diabetic kidney disease
5.Future direction of DKD management
Symposium 18
Clinical Application of New Insights into Water Electrolyte Metabolism in the Kidney
- Date
- 4:05pm - 6:05pm, Saturday, June 21
- Venue
- Room 9(4F G403+G404)
- Chair
- Fumiaki AndoInstitute of Science Tokyo
- Chair
- Mamiko OharaKameda Medical Center
- Speaker
- Fumiaki AndoInstitute of Science Tokyo
- Speaker
- Tsuyoshi InoueNagasaki University
- Speaker
- Tetsuro KusabaKyoto Prefectural University of Medicine
- Speaker
- Kengo AzushimaYokohama City University
- Speaker
- Richard S.E. Babicz Massachusetts General Hospital
1.LRBA is an anchoring protein essential for renal water and
sodium homeostasis
2.Elucidation of the regulatory mechanism of salt-sensitive
hypertension via the nervous system-immune system
3.Aversive response to high salt taste is impaired in CKD
patients
4.Skin tissue renin-angiotensin system as a new etiology of
hypertension
5.Epidermal growth factor signaling and water homeostasis:
novel insights in aquaporin-2 trafficking
Educational Lecture 13
SGLT2 inhibitor: from the perspective of body fluid balance changes
- Date
- 4:05pm - 5:05pm, Saturday, June 21
- Venue
- Room 8(4F G401+G402)
- Chair
- Tomohito GohdaJuntendo University
- Chair
- Hiroshi NishiThe University of Tokyo
- Speaker
- Daisuke NagataJichi Medical University
- Speaker
- Adriana MartonDuke-NUS Medical School / Klinikum Nuremberg
1.Benefits of SGLT2 inhibitors: From the perspective of
improving body fluid retention
2.SGLT2 inhibition induces aestivation-like body fluid
homeostasis in patients with chronic heart failure
Asian Session
- Date
- 9:00am - 11:30am, Friday, June 20
- Venue
- Room 5(3F G314+G315)
- Chair
- Yusuke SuzukiJuntendo University
- Chair
- Xueqing YuGuangdong Provincial People’s Hospital / Guangdong Academy of Medical Sciences
- Speaker
- Xueqing YuGuangdong Provincial People’s Hospital / Guangdong Academy of Medical Sciences
- Speaker
- Lim Soo KunUniversity Malaya Medical Centre
- Speaker
- Mai Szu WuTaipei Medical University
- Speaker
- Vuddhidej Ophascharoensuk Chiang Mai University
- Speaker
- Pringgodigdo Nugroho University of Indonesia
1.IgA Nephropathy Study: Current and Prospect
2.Chronic Kidney Disease Prevention Strategies: A Malaysian
Perspective
3.Kidney care in Taiwan - Leave No One Behind
4.Kidney Replacement Therapy Policy under Universal Coverage in Thailand: A Challenging Problem
5.Transforming CKD Care in Indonesia: From Awareness to Access
JSN/ERA Joint Symposium
- Date
- 2:00pm - 4:30pm, Friday, June 20
- Venue
- Room 5(3F G314+G315)
- Chair
- Motoko YanagitaKyoto University
- Chair
- Roser TorraFundació Puigvert / Universitat Autónoma de Barcelona
- Speaker
- Roser TorraFundació Puigvert / Universitat Autónoma de Barcelona
- Speaker
- Danilo FliserSaarland University Medical Centre
- Speaker
- Jasper CallemeynKU Leuven University
- Speaker
- Yusuke SuzukiJuntendo University
- Speaker
- Takashi YokooJikei University School of Medicine
- Speaker
- Hiraku TsujimotoCenter for iPS Cell Research and Application (CiRA), Kyoto University / Rege Nephro Co., Ltd.
1.Genetics of CKD
2.DKK3 and CKD progression – biomarker or more?
3.The multifaceted complexity of rejection after kidney
transplantation
4.Is IgA nephropathy an autoimmune disease caused by mucosal
infection?
5.Kidney xenotransplantation: toward first in human trial in
Japan
6.Development of methods for separately generating renal
embryonic progenitor cells from human iPSCs and the path to kidney regeneration
JSN/ASN Joint Symposium
- Date
- 9:00am - 11:00am, Saturday, June 21
- Venue
- Room 5(3F G314+G315)
- Chair
- Prabir Roy-ChaudhuryThe University of North Carolina at Chapel Hill
- Chair
- Reiko InagiThe University of Tokyo
- Speaker
- Jennifer L. PluznickJohns Hopkins School of Medicine
- Speaker
- Shinji KumeShiga University of Medical Science
- Speaker
- Janos Peti-Peterdi University of Southern California
- Speaker
- Takeshi YamamotoThe University of Osaka
1.Sex Differences in Blood Pressure: An Unexpected Role for a
Renal Olfactory Receptor
2.Fasting Response in the Kidney: Unraveling Its Role from
Physiology to Disease
3.Unconventional neuronal mechanisms in renal physiology,
tissue regeneration, and disease development
4.Autophagic Stagnation: A Key Mechanism in Kidney Disease
Progression Linked to Aging and Obesity
JSN/ISN Joint Symposium
- Date
- 3:30pm - 5:30pm, Saturday, June 21
- Venue
- Room 1(1F G3+G4)
- Chair
- Akira NishiyamaKagawa University
- Chair
- Marcello Tonelli University of Calgary
- Speaker
- Marcello Tonelli University of Calgary
- Speaker
- Meg JardineNHMRC CTC University of Sydney
- Speaker
- Motoko YanagitaKyoto University
- Speaker
- Shinji TanakaThe University of Tokyo Hospital
1.Hearing loss and the kidney. It’s not just Alport syndrome!
2.Navigating Chronic Kidney Disease Care: Strategic Selection of Treatment Options
3.When healing fails: mechanisms that limit kidney recovery
4.Neural control of kidney injury
JSN/KDIGO Joint Symposium
- Date
- 9:00am - 10:15am, Sunday, June 22
- Venue
- Room 5(3F G314+G315)
- Chair
- Adeera LevinUniversity of British Columbia
- Chair
- Shoichi MaruyamaNagoya University
- Speaker
- Adeera LevinUniversity of British Columbia
- Speaker
- Shoichi MaruyamaNagoya University
- Speaker
- Naoki NakagawaAsahikawa Medical University
- Speaker
- Tetsuhiro TanakaTohoku University
KDIGO guidelines for evaluation and management of CKD
JSN clinical practice guideline for CKD
Blood Pressure Management in CKD~Comparison between two
guidelines~
Anemia Management in CKD~Comparison between two guidelines~